Holen Sie sich die Stockscreener-App
114.23
1.61%
1.81
Handel nachbörslich:
114.23
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Abbott Laboratories Aktie (ABT) Neueste Nachrichten
M&T Bank Corp Has $110.42 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories: A Future-Driven Pharma Brand With A Robust Pipeline - Seeking Alpha
Abbott Whistleblower's False Claims Suit is Revived, Narrowed - Bloomberg Law
Abbott Labs stock target increased, buy rating on strong product lineup - Investing.com
The Zacks Analyst Blog Highlights Veracyte, Omnicell, Masimo and Abbott Laboratories - Yahoo Finance
XTX Topco Ltd Sells 31,480 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Abbott Laboratories stock outperforms competitors on strong trading day - MarketWatch
Abbott announces “first-in-world” leadless pacing procedures in left bundle branch area of heart - Cardiac Rhythm News
Implantable Loop Recorder Market Top Companies StudyAbbott - openPR
Syntax Research Inc. Makes New $2.28 Million Investment in Abbott Laboratories (NYSE:ABT) - MarketBeat
The Smartest Dividend Stocks to Buy With $500 Right Now - The Motley Fool
Biochips Market Huge Growth in Future Scope 2024-2031 | Abbott - openPR
Abbott (ABT) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Abbott Laboratories stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Cardiologists perform world’s first leadless LBBAP procedures with Abbott pacemaker - Cardiovascular Business
Abbott completes first-in-human leadless left bundle branch area pacing procedures - Mass Device
Cardiac Biomarkers Market CAGR of 13.3% Size, Current Trends, Future Prospects By 2024-2031 | Abbott - EIN News
Are Abbott Laboratories' (NYSE:ABT) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - Yahoo Finance
Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart - The Eastern Progress Online
Abbott Laboratories (ABT-N) QuotePress Release - The Globe and Mail
Abbott Laboratories stock outperforms competitors despite losses on the day - MarketWatch
How Abbott Labs Became a Dividend Growth Investor's Dream - MSN
How Abbott Labs Became A Dividend Growth Investor's Dream - Barchart
Abbott Laboratories a Top Ranked SAFE Dividend Stock With 2.1% Yield (ABT) - Nasdaq
Abbott Laboratories' SWOT analysis: medtech giant's stock faces litigation hurdles - Investing.com
Possible Bearish Signals With Abbott Laboratories Insiders Disposing Stock - Simply Wall St
B. Riley Wealth Advisors Inc. Sells 11,409 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Copley Financial Group Inc. Purchases New Shares in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Laboratories (NYSE:ABT) Shares Sold by Retirement Systems of Alabama - MarketBeat
Abbott Laboratories stock underperforms Friday when compared to competitors - MarketWatch
Abbott Increases Dividend Again, Showcasing Decades of Reliable Shareholder Returns - Yahoo Finance
Abbott boosts quarterly dividend to 59 cents, up 7.3% - Investing.com
Abbott Declares Quarterly Common Dividend, Payable February 14, 2025 - Marketscreener.com
Abbott Labs Extends Royal Dividend Run With 7.3% Increase - Marketscreener.com
Abbott Increases Quarterly Dividend for 53rd Consecutive Year - The Eastern Progress Online
NEC Baby Formula Lawsuit - Lawsuit Information Center Blog
Tidal Investments LLC Purchases 25,052 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Franklin Resources Inc. Has $1.14 Billion Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
UPC deals further blow to Dexcom in glucose monitor dispute with Abbott - Life Sciences Intellectual Property Review
Stock Yards Bank & Trust Co. Has $38.17 Million Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Dexcom suffers third successive patent loss in Abbott UPC dispute - IAM
Abbott (ABT) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Jim Cramer Says 'Keep Owning' This Energy Stock, Abbott Laboratories 'Legal Stuff' Is Behind Them - Benzinga
Abbott Laboratories (NYSE:ABT) Shares Acquired by Teachers Retirement System of The State of Kentucky - MarketBeat
Toronto Dominion Bank Sells 220,223 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Groupama Asset Managment Boosts Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Baby Nutrition Market Size, Growth Status to 2033 Danone, Abbott - openPR
Lightning Round: Abbott Labs' legal trouble is largely behind it, says Jim Cramer - MSN
Cramer's Lightning Round: 'Keep owning' Energy Transfer - CNBC
Abbott Laboratories (NYSE:ABT) Shares Acquired by Geode Capital Management LLC - MarketBeat
Vestcor Inc Has $7.35 Million Position in Abbott Laboratories (NYSE:ABT) - MarketBeat
Abbott Expands Biowearables for Health and Wellness - The Healthcare Technology Report.
Is Abbott Laboratories Stock Underperforming the Nasdaq? - MSN
Why Is Abbott Laboratories (ABT) Among the Best Dividend Kings to Invest In For Safe Dividend Growth? - Yahoo Finance
Abbott Laboratories (HAM:ABL) 10-Year Sharpe Ratio : 0.64 (As of Dec. 09, 2024) - GuruFocus.com
Abbott Laboratories stock underperforms Monday when compared to competitors - MarketWatch
Prostate Cancer Diagnostics Industry Business Report 2024 - GlobeNewswire Inc.
Diabetes Devices Market Next Big Thing | Major Giants- Abbott Laboratories, Bayer AG, Lifescan - openPR
Insiders At Abbott Laboratories Sold US$3.0m In Stock, Alluding To Potential Weakness - Yahoo Finance
Y Intercept Hong Kong Ltd Buys New Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
Nomura Asset Management Co. Ltd. Purchases 68,779 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
Medical Nutrition Market Top Companies StudyAbbott - openPR
First National Bank of Omaha Buys 5,683 Shares of Abbott Laboratories (NYSE:ABT) - MarketBeat
MML Investors Services LLC Boosts Stock Holdings in Abbott Laboratories (NYSE:ABT) - MarketBeat
2.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):